A randomized, double-blind clinical trial of canrenone vs hydrochlorothiazide in addition to angiotensin II receptor blockers in hypertensive type 2 diabetic patients
Articolo
Data di Pubblicazione:
2018
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
Canrenone; Hydrochlorothiazide; Metabolism; Type 2 diabetes mellitus; Angiotensin Receptor Antagonists; Antihypertensive Agents; Canrenone; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Humans; Hydrochlorothiazide; Male; Middle Aged; Pharmacology; 3003; Drug Discovery3003 Pharmaceutical Science
Elenco autori:
Derosa, Giuseppe; Gaudio, Giovanni; Pasini, Gianfranco; D’Angelo, Angela; Maffioli, Pamela
Link alla scheda completa:
Pubblicato in: